Satralizumab Interactions
There are 357 drugs known to interact with satralizumab, along with 3 disease interactions. Of the total drug interactions, 61 are major, 288 are moderate, and 8 are minor.
- View all 357 medications that may interact with satralizumab
- View satralizumab disease interactions (3)
Most frequently checked interactions
View interaction reports for satralizumab and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Ambien (zolpidem)
- Amrix (cyclobenzaprine)
- Andexxa (coagulation factor Xa)
- Banzel (rufinamide)
- Bonine (meclizine)
- Brilinta (ticagrelor)
- Briviact (brivaracetam)
- BuSpar (buspirone)
- Celexa (citalopram)
- Concerta (methylphenidate)
- Copaxone (glatiramer)
- Coreg (carvedilol)
- Coumadin (warfarin)
- Cytoxan (cyclophosphamide)
- Daytrana (methylphenidate)
- Eliquis (apixaban)
- Emgality (galcanezumab)
- Firdapse (amifampridine)
- Focalin (dexmethylphenidate)
- Humira (adalimumab)
- Intuniv (guanfacine)
- Jakafi (ruxolitinib)
- Kapvay (clonidine)
- Keytruda (pembrolizumab)
- Klonopin (clonazepam)
- Levophed (norepinephrine)
Satralizumab disease interactions
There are 3 disease interactions with satralizumab which include:
Report options
QR code containing a link to this page
More about satralizumab
- satralizumab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
